Elizabeth Mallon

Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

Bernhard C. Pestalozzi, David Zahrieh, Elizabeth Mallon et al. · Journal of Clinical Oncology · 2008 · 484 citations · Full text

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial

Mitch Dowsett, Craig Allred, Jill Knox et al. · Journal of Clinical Oncology · 2008 · 463 citations

Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer

Ivana Šestak, Richard Buus, Jack Cuzick et al. · JAMA Oncology · 2018 · 322 citations · Full text

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

Ian Smith, J.F.R. Robertson, Lucy Kilburn et al. · The Lancet Oncology · 2020 · 299 citations · Full text

Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis

Suzanne Hagan, Fahd Al‐Mulla, Elizabeth Mallon et al. · Clinical Cancer Research · 2005 · 261 citations